Bloomberg: Japan got Seroquel warning before U.S.

Bloomberg has been hot on the trail of the Seroquel litigation, and in its latest foray into newly unsealed documents, found that AstraZeneca in 2002 warned Japanese doctors of diabetes cases in Seroquel patients "where causality with the drug could not be ruled out." Similar U.S. warnings did not come until 2004, the news service states. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.